Carlson Douglas R
See Remarks
Carlson Douglas R has filed 1 SEC Form 4 filing (4 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Nov 19, 2026.
On the most recent filing, Carlson Douglas R is listed as See Remarks at Avalyn Pharma Inc. Inside the rolling window, Carlson Douglas R reported no open-market purchases and 1 open-market sale totaling $415K in AVLN.
Companies traded
Other insiders at AVLN
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$415K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Carlson Douglas R made?
Carlson Douglas R has filed 1 SEC Form 4 filing (4 transaction rows) across 1 company since 2026.
Which companies does Carlson Douglas R trade?
Carlson Douglas R has filed SEC Form 4 disclosures for 1 company, including AVLN.
When was Carlson Douglas R's most recent SEC Form 4 filing?
Carlson Douglas R's most recent SEC Form 4 filing on Tracefour is dated Nov 19, 2026.
What is Carlson Douglas R's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Carlson Douglas R is listed as See Remarks.
What is Carlson Douglas R's total buy and sell value in the current window?
Inside the rolling retention window, Carlson Douglas R bought $0 and sold $415K based on SEC Form 4 filings.
What was Carlson Douglas R's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 14,875 AVLN shares on 2026-11-17, worth $415K, per SEC Form 4 filings.